Precision Medicine Market 2017 Global Analysis, Opportunities and Forecast To 2022
Apr 7, 2017
Precision Medicine -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022
Pune , India - April 7, 2017 /MarketersMedia/ —
Precision Medicine Industry
Description
Wiseguyreports.Com Adds “Precision Medicine -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database
This report studies Precision Medicine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AB-Biotics Sa
Abbott Laboratories
Almac Group
Asuragen
Biobase Gmbh (Subsidiary)
Biomérieux Sa
Caris Life Sciences
Cepheid Inc.
Cetics Healthcare Technologies Gmbh
GE Healthcare
Glaxosmithkline (Gsk)
Healthcore
IBM
Intel Corporation
Intomics A/S
Johnson & Johnson
Laboratory Corporation Of America Holdings
Medtronic
Novartis
Qiagen
Quest Diagnostics
Randox Laboratories
Roche Holding Ag-Br
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/730541-global-precision-medicine-market-research-report-2016
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Precision Medicine in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Drug discovery
Companion diagnostics
Sequencing
Bio-informatics
Others
Split by application, this report focuses on consumption, market share and growth rate of Precision Medicine in each application, can be divided into
Oncology
CNS
Immunology
Respiratory
Others
Leave a Query @ https://www.wiseguyreports.com/enquiry/730541-global-precision-medicine-market-research-report-2016
Table of Contents
Global Precision Medicine Market Research Report 2016
1 Precision Medicine Market Overview
1.1 Product Overview and Scope of Precision Medicine
1.2 Precision Medicine Segment by Type
1.2.1 Global Production Market Share of Precision Medicine by Type in 2015
1.2.2 Drug discovery
1.2.3 Companion diagnostics
1.2.4 Sequencing
1.2.5 Bio-informatics
1.2.6 Others
1.3 Precision Medicine Segment by Application
1.3.1 Precision Medicine Consumption Market Share by Application in 2015
1.3.2 Oncology
1.3.3 CNS
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Precision Medicine Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Precision Medicine (2011-2021)
...
7 Global Precision Medicine Manufacturers Profiles/Analysis
7.1 AB-Biotics Sa
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Precision Medicine Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 AB-Biotics Sa Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Precision Medicine Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Abbott Laboratories Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Almac Group
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Precision Medicine Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Almac Group Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Asuragen
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Precision Medicine Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Asuragen Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Biobase Gmbh (Subsidiary)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Precision Medicine Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Biobase Gmbh (Subsidiary) Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Biomérieux Sa
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Precision Medicine Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Biomérieux Sa Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Caris Life Sciences
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Precision Medicine Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Caris Life Sciences Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Cepheid Inc.
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Precision Medicine Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Cepheid Inc. Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Cetics Healthcare Technologies Gmbh
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Precision Medicine Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Cetics Healthcare Technologies Gmbh Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 GE Healthcare
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Precision Medicine Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 GE Healthcare Precision Medicine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Glaxosmithkline (Gsk)
7.12 Healthcore
7.13 IBM
7.14 Intel Corporation
7.15 Intomics A/S
7.16 Johnson & Johnson
7.17 Laboratory Corporation Of America Holdings
7.18 Medtronic
7.19 Novartis
7.20 Qiagen
7.21 Quest Diagnostics
7.22 Randox Laboratories
7.23 Roche Holding Ag-Br
7.24 Takeda Pharmaceutical Company
7.25 Teva Pharmaceutical Industries
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=730541
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Phone: +91 841 198 5042
For more information, please visit https://www.wiseguyreports.com/sample-request/730541-global-precision-medicine-market-research-report-2016
Source: MarketersMedia
Release ID: 184278
More News
Post-mortem underway after man found dead in Brisbane
Police remain at the scene in Chermside where the body of a man was found on Sunday.
Graphics: China's engagement in global governance
Graphics: China's engagement in global governance
Great Southern uncovers new high-grade hits in WA gold hunt
Great Southern has hit high-grade gold in maiden RC drilling near Laverton in WA, with a top hit of 5m at 6.71g/t, including 3m at 10.4g/t, along a 4.7km corridor.
‘I committed heinous crimes’: Moore Park rapist’s message to victims revealed
His crimes terrified Sydney for years. Now the serial rapist has broken his silence.
President Lee's approval rating rebounds after 2-week decline: poll
President Lee Jae Myung's approval rating rebounded to 37.3 percent after two consecutive weeks of decline, a survey showed Monday. In the poll conducted on 2,520 adults nationwide from last Monday to Friday by Realmeter, positive assessments of Lee's job performance rose 2.1 percentage points from the previous week. Negative assessments fell 1 percentage point to 60.4 percent. As reasons for the rebound, Realmeter cited policies aimed at improving people's livelihoods in areas such as housing and jobs, as well as the government's measures to tackle violent crimes following a stabbing spree in Incheon, west of Seoul. The pollster added that a sharp stock market decline later in the week appeared to have weighed on Lee's approval rating. In a separate survey of 1,005 adults conducted between Thursday and Friday, support for the ruling Democratic Party of Korea rose 0.7 percentage point to 36.2 percent, while that of the main opposition People Power Party fell 0.4 percentage point to 40.9 percent. The survey on the president had a margin of error of 2 percentage points at a 95 percent confid
Chungnam National University offers hands-on agricultural programs
Chungnam National University is nurturing future agricultural workers through programs that give university and high school students practical experience in crop cultivation and harvesting. The university said its Department of Crop Science and GreenBio Convergence and Open Sharing System (COSS) project group held the “2026 Morakmorak Nongshim” green bio career exploration program at the university's affiliated farm on Friday. The program brought together about 60 participants, including students from the university and Yuseong Bio Science Technology High School in Daejeon. Under the guidance of professor Shim Kyu-chan, participants harvested wild rice, while professor Lee Sung-woo led a session on soybean harvesting. They learned about the ecological value of wild rice as a genetic resource and the importance of conserving native seeds. Explanations of crop growth characteristics and cultivation and harvesting methods also helped participants better understand the diversity of food crops and the need to preserve genetic resources. The program builds on the “Green Bio Mo-ment Program
1 KATUSA killed, 3 USFK soldiers injured in rollover crash in Daegu
DAEGU — One Korean soldier attached to the U.S. Forces Korea (USFK) was killed and three others, including two U.S. servicemembers, were injured Monday after their vehicle crashed in the southeastern city of Daegu, local police said. Their military sport utility vehicle (SUV) crashed into a median strip and flipped onto its right side on a highway in the city about 240 kilometers southeast of Seoul, at 5:07 a.m., the police said. One Korean soldier in his 20s, who was serving as a Korean Augmentation to the U.S. Army (KATUSA), died in the crash, while another KATUSA soldier, also in his 20s, sustained serious but non-life-threatening injuries, according to the police. Two USFK servicemembers suffered minor injuries. The four soldiers were returning to their base after completing their shift in Daegu's Chilgok County. The police said they notified the USFK of the accident and are investigating the details.
Yongsan to deploy 2,550 personnel in Itaewon to prevent repeat of Halloween tragedy
With the approach of Oct. 31, a Saturday that promises packed streets and spirited celebrations, local authorities in the heart of the capital are taking no chances. The Yongsan District Office announced a comprehensive safety mobilization Monday for the upcoming Halloween season, deploying thousands of personnel and leveraging real-time data technology to safeguard visitors in the bustling Itaewon neighborhood. The heightened security measures reflect a deep, ongoing commitment to preventing any repetition of the tragic 2022 Halloween crowd crush, which claimed 159 lives in a narrow alleyway in Itaewon. In the years since, local authorities and disaster response agencies have completely overhauled urban safety protocols, turning the nightlife district into a testing ground for real-time crowd management. Running Oct. 23 to Nov. 1, a special 10-day safety enforcement period aims to manage an anticipated crowd of 165,000 visitors across popular nightlife corridors such as the World Food Street. The comprehensive plan blends boots-on-the-ground vigilance with advanced digital monitoring. A
Inaugural SCIA chief reaffirms pledge to end 'politicization' of investigations
The inaugural chief of the Serious Crime Investigation Agency (SCIA) on Monday reiterated his pledge to end the "politicization" of investigations. Kim Ji-yong was appointed to lead the newly launched agency Thursday following a major overhaul to the criminal justice system earlier this month that stripped prosecutors of their investigative powers. "The previous prosecution caused various harms, such as abusing investigative powers, and I think the root cause of that lies with the politicization of investigations," he told reporters. "The SCIA will establish itself as an investigative agency that the public will not have to worry about by strictly upholding fairness, neutrality and procedural justice." Kim, as nominee, had vowed to prioritize ending the "politicization" of investigations. The SCIA was launched on Oct. 2 as part of reforms to the prosecution amid criticism that prosecutors pursued politically motivated investigations.
Rare earths strike in NT extends 8km beyond previous Barkly hits
Barkly Rare Earths has expanded its NT rare earths discovery, with new drilling hitting significant intercepts up to 8km from previous results, including high-grade hits up to 4550ppm TREO.
China's GDP expands 4.6% YoY in first three quarters
China's GDP expands 4.6% YoY in first three quarters
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.